A recent tendency of protein drug delivery system for bioefficacy improvement

Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 4-6, 2008, Pages 587-593

  Lee, Ju Young ^a,b   Kim, Kyung Sook ^a,c   Lee, Jung Hwa ^a,c   Hwang, Sung Joo ^b   Lee, Bong ^c   Khang, Gilson ^d   Lee, Hai Bang ^a   Kim, Moon Suk ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Chungnam National University   (South Korea)

^c Pukyong National University   (South Korea)

^d Chonbuk National University   (South Korea)

Author keywords

Bioefficacy; Delivery system; Protein drug; Stability

Indexed keywords

BIOEFFICACY; DELIVERY SYSTEMS; DRUG DELIVERY SYSTEM; MICROCAPSULES; PROTEIN DRUG DELIVERY; PROTEIN DRUGS; PROTEIN-DRUG; RECENT TRENDS;

CONVERGENCE OF NUMERICAL METHODS; DRUG DELIVERY; SYSTEM STABILITY;

PROTEINS;

EID: 80054686923     PISSN: 17382696     EISSN: 22125469     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. DK Malik, S Baboota, A Ahuja, et al., Recent advances in protein and peptide drug delivery systems, Curr Drug Deliv, 4(2), 141 (2007).
2. LR Brown, Commercial challenges of protein drug delivery, Expert Opin Drug Deliv, 2(1), 29 (2005).
3. JR Murphy, Protein engineering and design for drug delivery, Curr Opin Struct Biol, 6(4), 541 (1996).
4. LM Sanders, Drug delivery systems and routes of administration of peptide and protein drugs, Eur J Drug Metab Pharmacokinet, 15(2), 95 (1990).
5. W Wang, Oral protein drug delivery, J Drug Target, 4(4), 195
6. G Khang, MS Kim, BH Min, et al., Scaffolds for tissue engineering, Tissue Eng Regen Med, 3(4), 376 (2006).
7. S Frokjaer, DD Otzen, Protein drug stability: a formulation challenge, Nat Rev Drug Discov, 4, 298 (2005).
8. M Morishita, NA Peppas, Is the oral route possible for peptide and protein drug delivery?, Drug Discov Today, 11(19-20), 905 (2006).
9. RI Mahato, AS Narang, L Thoma, et al., Emerging trends in oral delivery of peptide and proteins, Crit Rev Ther Drug Carrier Syst, 20, 153 (2003).
10. S Sakuma, T Matsumoto, S Yamashita, et al., Conjugation of poorly absorptive drugs with mucoadhesive polymers for the improvement of oral absorption of drugs, J Control Release, 123(3), 195 (2007).
11. FM Veronese, JM Harris, Introduction and overview of peptide and protein pegylation, Adv Drug Deliv Rev, 54, 453 (2002).
12. AS Hoffman, PS Stayton, Conjugates of stimuli-responsive polymers and proteins, Prog Poly Sci, 32, 922 (2007).
13. MI Roberts, MD Bentley, JM Harris, Chemistry for peptide and protein PEGylation, Adv Drug Deliv Rev, 54, 459 (2002).
14. A Abuchowski, GM Kazo, CR Verhoest, et al., Cancer therapy with chemically modified enzymes I Antitumor properties of polyethylene glycol-asparaginase conjugates, Cancer Biochem Biophys, 7, 175 (1984).
15. AR Ettinger, Pegaspargase(Oncaspar), J Pediatr Oncol Nurs, 12, 46 (1995).
16. LM Holle, Pegaspargase: an alternative?, Ann Pharmacother, 31, 616 (1997).
17. S Youngster, YS Wang, M Grace, et al., Structure, biology, and therapeutic implications of pegylated interferon alpha-2b, Curr Pharm Des, 8, 2139 (2002).
18. R Bukowski, MS Ernstoff, ME Gore, et al., Pegylated interferon alfa-2b treatment for patients with solid tumors: a phase I/II study, J Clin Oncol, 20, 3841 (2002).
19. M Shakweh, M Besnard, V Nicolas, et al., Poly(lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice, Eur J Pharm Biopharm, 61, 113 (2005).
20. MP Desai, V Labhasetwar, E Walter, et al., The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent, Pharm Res, 14, 1568 (1997).
21. A Béduneau, P Saulnier, JP Benoit, Active targeting of brain tumors using nanocarriers, Biomaterials, 28(33), 4947 (2007).
22. Y Pan, YJ Li, HY Zhao, et al, Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo, Int J Pharm, 249, 139 (2002).
23. Z Ma, TM Lim, LY Lim, Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats, Int J Pharm, 293, 271 (2005).
24. AT Florence, Issues in oral nanoparticle drug carrier uptake and targeting, J Drug Target, 12, 65 (2004).
25. KB Chalasani, GJ Russell-Jones, AK Jain, et al., Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles, J Control Release, 122(2), 141 (2007).
26. T Akagi, X Wang, T Uto, Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives, Biomaterials, 28(23), 3427 (2007).
27. KW Leong, R Langer, Polymeric controlled drug delivery, from poly(lactide-co-glycolide) microspheres, Adv Drug Deliv Rev, 1, 199 (1987).
28. R Narazaki, R Sanghvi, SH Yalkowsky, Estimation of drug precipitation upon dilution of pH-controlled formulations, Mol Pharm, 4, 550 (2007).
29. SB Jung, GD Kang, JY Huh, et al., Thermosensitive biodegradable poly(organophosphazene) gels and their blends, Tissue Eng Regen Med, 3(2), 108 (2006).
30. P Tyagi, PC Wu, M Chancellor, et al, Recent advances in intravesical drug/gene delivery, Mol Pharm, 3, 369 (2006).
31. JW Lee, H Hyun, JS Cho, et al., The effect of crystallinity on release Behavior of Albumin from MPEG-polyesters vehicles, Tissue Eng Regen Med, 4(3), 399 (2007).
32. TW Lee, G Khang, SJ Hwang, et al., Evaluation of wound healing for hydrogel containing chitosan, Tissue Eng Regen Med, 4(1), 73 (2007).
33. YH Kim, JW Lee, MS Kim, et al., Application of poly(vinylalcohol) as drug delivery carrier, Tissue Eng Regen Med, 3(2), 96 (2006).
34. HJ Chung, Y Lee, TG Park, Thermo-sensitive and biodegradable hydrogels based on stereocomplexed Pluronic multi-block copolymers for controlled protein delivery, J Control Release, 127(1), 22 (2008).
35. A Khademhosseini, R Langer, Microengineered hydrogels for tissue engineering, Biomaterials, 28(34), 5087 (2007).
36. C Hiemstra, Z Zhong, SR Van Tomme, et al., in vitro and in vivo protein delivery from in situ forming poly(ethylene glycol)-poly(lactide) hydrogels, J Control Release, 119(3), 320 (2007).
37. RT Bartus, MA Tracy, DF Emerich, et al., Sustained delivery of proteins for novel therapeutic agents, Science, 281, 1161 (1998).
38. R Langer, New methods of drug delivery, Science, 249, 1527 (1990).
39. KE Uhrich, SM Cannizzaro, RS Langer, et al., Polymeric systems for controlled drug release, Chem Rev, 99, 3181 (1999).
40. DD Breimer, Future challenges for drug delivery research, Adv Drug Delivery Rev, 33, 265 (1998).
41. MH Cho, SK Kim, H Hyun, et al., Sustained release of BDNF using temperature sensitive MPEG-PCL hydrogels, Tissue Eng Regen Med, 3(1), 46 (2006).
42. L Liguori, B Marques, A Villegas-Mendez, et al, Liposomes-mediated delivery of pro-apoptotic therapeutic membrane proteins, J Control Release, 126(3), 217 (2008).
43. F Yuan, M Leunig, SK Huang, et al., Microvascular permeability and interstitial penetration of sterically stabilized(stealth) liposomes in a human tumor xenograft, Cancer Res, 54, 33 (1994).
44. AA Gabizon, Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy, Cancer Invest, 19, 424 (2001).
45. T Hwang, HD Han, DH Seo, et al., Enhanced intracellular uptake of anticancer agent by liposomes modified with folate-poly(ethylene imine)-phospholipid conjugates, Tissue Eng Regen Med, 3(2), 114 (2006).
46. V Weissig, KR Whiteman, VP Torchilin, Accumulation of protein-loaded long circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice, Pharm Res, 15, 1552 (1998).
47. SK Hobbs, WL Monsky, F Yuan, et al., Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment, Proc Natl Acad Sci U S A, 95, 4607 (1998).
48. VS Trubetskoy, VP Torchilin, Use of polyoxyethylene-lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents, Adv Drug Deliv Rev, 16, 311 (1995).
49. KY Lee, SH Yuk, Polymeric protein delivery systems, Prog Poly Sci, 32, 669 (2007).
50. M Lee, TT Chen, ML Iruela-Arispe, et al, Modulation of protein delivery from modular polymer scaffolds, Biomaterials, 28(10), 1862 (2007).
51. JW So, SH Kim, MO Baek, et al., Effect of size of PLGA microsphere on proliferation and phenotype for human intervertebral disc cells, Tissue Eng Regen Med, 4(4), 577 (2007).
52. JH Park, M Y.e., Y Yeo, et al, Reservoir-type microcapsules prepared by the solvent exchange method: effect of formulation parameters on microencapsulation of lysozyme, Mol Pharm, 3, 135 (2006).